An Emeryville company attempting to tap an Australian weed for a treatment of a precancerous skin condition has landed a new top management team and a $24 million investment after a failed IPO.

Lees meer..

KV Pharmaceutical Co. is awaiting an October deadline for federal approval of a drug anticipated to boost company revenue while combating a national health epidemic — preterm births.

Lees meer..

An 11th-hour attempt to extend a key patent could cost companies — including a small East Bay cardiovascular catheter maker — millions in potential revenue.

Lees meer..

Frederick H. Hausheer, M.D., is the founder, chairman and CEO of BioNumerik Pharmaceuticals,Inc. and co-founder, chairman and CEO of KI Pharma LLC., Japan. He is an adjunct associate professor at The Johns Hopkins Oncology Center and The University of Texas Health Sciences Center at San Antonio, as well as a business advisory board member at JP Morgan Chase Bank. He holds a bachelor’s in biology from Graceland College, a master’s from the University of Illinois in Urbana, and a medical degree from the University of Missouri School of Medicine. Hausheer has co-authored more than 150 medical and scientific research publications and is the inventor or co-inventor on more than 200 U.S. and international patents and patent applications involving new pharmaceutical agents, formulations and methods of use for cancer treatment and other diseases. He talks with the Business Journal about Tavocept, a lung cancer drug BioNumerik has in late-stage clinical development.

Lees meer..

Cancer is a fact of life in the United States. We have almost all been touched by it in some way. Cancer is already the second leading cause of death in the United States, and is the primary cause of death in women between the ages of 35 and 74. Cancer does not spare children, either, being the chief cause of death between ages 1 to 14. Cancer will likely surpass cardiovascular disease to become the leading cause of death in the United States within two years, where someone already dies from cancer every 90 seconds.

Lees meer..

Claes Wahlestedt, who heads Scripps Florida’s efforts to develop drugs for diseases of the central nervous system, has launched new company with business consultant and longtime friend Joe Collard.

Lees meer..

A Georgia legislator wants to examine how the state university system governs its intellectual property — an issue prompted by The University of Georgia Research Foundation Inc.’s dealings with a giant pharmaceutical company.

Lees meer..

RESEARCH TRIANGLE PARK – The pending $3.1 billion purchase of Talecris Biotherapeutics is not a done deal, and there’s a small but real chance that the deal won’t go through.

Lees meer..

A quarter century ago when heavy manufacturing — then the lifeblood of Pennsylvania’s economy — was showing signs of terminal decline, state lawmakers and business leaders began searching for remedies to breathe new life into the economic base of the state. The remedy for the technology sector came in the form of the law signed by then-Gov. Richard Thornburgh, creating the Ben Franklin Technology Partners (BFTP) to bring investment capital, entrepreneurial knowledge and the infrastructure to provide the seed funding needed to support tech growth.

Lees meer..

Hersenweefselverlies bepaalt ziekteverloop MS
Lees meer..